期刊文献+

分化型甲状腺癌术后促甲状腺素抑制治疗现状 被引量:6

Post-operation TSH suppression therapy in differentiated thyroid carcinoma
原文传递
导出
摘要 外科手术依然是甲状腺癌尤其是分化型甲状腺癌的主要治疗手段,术后内分泌治疗被认为是重要的辅助治疗手段,其不仅可以防止术后发生甲状腺功能低下,而且能降低甲状腺癌患者术后的复发率及死亡率。 Surgical operation is still the main means of thyroid carcinoma,especially the differentiated thyroid carcinoma. Postoperative endocrine therapy is considered as an important adjuvant therapy. Giving the corresponding endocrine therapy after the surgery,not only prevent the hypothyroidism,but also reduce the recurrence rate and mortality in postoperative patients with thyroid carcinoma.
出处 《国际肿瘤学杂志》 CAS 2014年第8期585-588,共4页 Journal of International Oncology
基金 卫生部科学研究基金-浙江省医药卫生重大科技计划(WKJ2012-2-021);浙江省卫生高层次创新人才培养工程基金
关键词 乳头状 甲状腺肿瘤 治疗 Carcinoma, papillary Thyroid neoplasms Therapy
  • 相关文献

参考文献19

  • 1Agate L, Lorusso L, Elisei R. New and old knowledge on differentiated thyroid cancer epidemiology and risk factors[J]. J Endocrinol Invest, 2012, 35 Suppl 6:3-9.
  • 2Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths[J].CA Cancer J Clin.2011, 61(4):212-236.
  • 3American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid.2009, 19(11):1167-1214.
  • 4Alagi′cSmailbegovi′c J, Kucukali′cSelimovi′c E, Seti′c I, et al. Importance of measurement of thyroglobulin and antithyroglobulin antibodies in differentiated thyroid cancer[J]. Coll Antropol, 2012, 36 Suppl 2:33-38.
  • 5McLeod DS, Watters KF, Carpenter AD, et al. Thyrotropin and thyroid cancer diagnosis:a systematic review and doseresponse metaanalysis[J].J Clin Endocrinol Metab.2012, 97(8):2682-2692.
  • 6Brabant G. Thyrotropin suppressive therapy in thyroid carcinoma:what are the targets?[J].J Clin Endocrinol Metab.2008, 93(4):1167-1169.
  • 7Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer[J].Thyroid.2010, 20(2):135-146.
  • 8Pacini F, Castagna MG, Brilli L, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup[J]. Ann Oncol, 2012, 23 Suppl 7:110-119.
  • 9Hovens GC, Stokkel MP, Kievit J, et al. Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer[J].J Clin Endocrinol Metab.2007, 92(7):2610-2615.
  • 10Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction[J].Endocr Rev.2008, 29(1):76-131.

二级参考文献5

共引文献17

同被引文献57

引证文献6

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部